MASTER IN MANUFACTURING OF ADVANCED THERAPY MEDICINAL PRODUCTS
With recent commercial approvals of the first cell therapies, new treatments have entered the market with manufacturing processes that differ greatly from standard pharmaceutical products. In May 2018 new Guidelines on Good Manufacturing Practice (GMP) specific for Advanced Therapy Medicinal Products (ATMPs) came into force in Europe. The demand for specialists in process development, manufacturing, quality management and regulatory affairs is large and will continue to grow in the next years.
To facilitate growth in the cell and gene therapy space CellGenix is proud to support the Master programme in Manufacturing of Advanced Therapy Medicinal Products organized by the Andalusian Initiative for Advanced Therapies and the University of Granada with the collaboration of the Línea IAVANTE ‐ Progress and Health Foundation.
The program offers the following degrees:
- Master in Manufacturing of Advanced Therapy Medicinal Products, specialization as Qualified Person
- Master in Manufacturing of Advanced Therapy Medicinal Products, specialization as Manufacturing Manager
- Master in Manufacturing of Advanced Therapy Medicinal Products, specialization as Quality Control Manager
- Expert in Quality Assurance for Manufacturing of Advanced Therapy Medicinal Products
The target audience for this pioneering Master’s program are professionals aspiring for advancement, presently working (or intending to do so) in GMP‐compliant facilities producing cell therapy, gene therapy or tissue engineered products. It is not intended for biomedical students pursuing a Ph.D. in regenerative medicine or related subjects.
With the collaboration of:
Take your chance for tuition support from CellGenix!
In 2019/2020 CellGenix will support one student with a 40% discount on the tuition fee.
Convince us why we should contribute your next career step. Send us a summary why you want to pursue this degree and where you see your future in the field of ATMPs (max. 1 page). E-mail us to email@example.com
*to be eligible for the financial support you must be accepted into the 2019/2020 program and in good standing with the University of Granada (proof needed). Decisions regarding this stipend will be made under sole criteria of CellGenix. Deadline for the application is January 20, 2019, 14:00 (CET). Void where prohibited.